Federal Register / Vol. 87, No. 65 / Tuesday, April 5, 2022 / Notices 19689 

conclusions, and recommendations for legislative or 

agency action. 

5Section 10(3) and section 11 of the FRA 

authorize the Board to manage its buildings and 

staff. 12 U.S.C. 243 and 248(1). Section 10(4) of the 

FRA authorizes the Board to determine and 

prescribe the manner in which its obligations shall 

be incurred and its disbursements and expenses 

allowed and paid. 12 U.S.C. 244. 

6 12 U.S.C. 5452(c) (requiring the Board to 

develop and implement standards and procedures 

for the review and evaluation of contract proposals 

and for hiring service providers that include a 

component that gives consideration to the diversity 

of a prospective supplier and the fair inclusion of 

women and minorities in the workforce of such 

supplier and any subcontractor). 

7 5 U.S.C. 552(b)(4). 

8 5 U.S.C. 552(b)(6). 

Legal authorization and 

confidentiality: The filing requirements 

under the FR 1400 are authorized by 

sections 10 and 11 of the Federal 

Reserve Act (FRA) 5 and section 342(c) 

of the Dodd-Frank Act.6 Registering in 

the Supplier Registration System (FR 

1400A) is voluntary. The remaining 

portions of the FR 1400 (FR 1400B, FR 

1400C, and FR 1400D) are required to 

obtain a benefit for prospective 

suppliers to the Board. 

A prospective supplier may request 

confidential treatment of information 

submitted as part of its Procurement 

Solicitation Package under exemption 4 

of the Freedom of Information Act 

(FOIA), which protects commercial or 

financial information that is both 

customarily and actually treated as 

private.7 In addition, a prospective 

supplier may request confidential 

treatment of information pursuant to 

exemption 6 of the FOIA, which 

protects personal information, the 

disclosure of which would ‘‘constitute a 

clearly unwarranted invasion of 

privacy.’’ 8 Determinations of 

confidentiality based on exemption 4 or 

exemption 6 of the FOIA would be 

made on a case-by-case basis. 

Current actions: On November 23, 

2021, the Board published a notice in 

the Federal Register (86 FR 66557) 

requesting public comment for 60 days 

on the extension, without revision, of 

the Procurement Solicitation Package. 

The comment period for this notice 

expired on January 24, 2022. The Board 

did not receive any comments. 

Board of Governors of the Federal Reserve 

System, April 1, 2022. 

Margaret Shanks, 

Deputy Secretary of the Board. 

[FR Doc. 2022–07223 Filed 4–4–22; 8:45 am] 

BILLING CODE 6210–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier: CMS–10416] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, Health and Human 

Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Medicare & 

Medicaid Services (CMS) is announcing 

an opportunity for the public to 

comment on CMS’ intention to collect 

information from the public. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), federal agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information (including each proposed 

extension or reinstatement of an existing 

collection of information) and to allow 

60 days for public comment on the 

proposed action. Interested persons are 

invited to send comments regarding our 

burden estimates or any other aspect of 

this collection of information, including 

the necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions, 

the accuracy of the estimated burden, 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected, and the use of automated 

collection techniques or other forms of 

information technology to minimize the 

information collection burden. 

DATES: Comments must be received by 

June 6, 2022. 

ADDRESSES: When commenting, please 

reference the document identifier or 

OMB control number. To be assured 

consideration, comments and 

recommendations must be submitted in 

any one of the following ways: 

1. Electronically. You may send your 

comments electronically to http://

www.regulations.gov. Follow the 

instructions for ‘‘Comment or 

Submission’’ or ‘‘More Search Options’’ 

to find the information collection 

document(s) that are accepting 

comments. 

2. By regular mail. You may mail 

written comments to the following 

address: CMS, Office of Strategic 

Operations and Regulatory Affairs, 

Division of Regulations Development, 

Attention: Document Identifier/OMB 

Control Number: lll, Room C4–26– 

05, 7500 Security Boulevard, Baltimore, 

Maryland 21244–1850. 

To obtain copies of a supporting 

statement and any related forms for the 

proposed collection(s) summarized in 

this notice, you may make your request 

using one of following: 

1. Access CMS’ website address at 

website address at https://www.cms.gov/ 

Regulations-and-Guidance/Legislation/ 

PaperworkReductionActof1995/PRAListing. 

FOR FURTHER INFORMATION CONTACT: 

William N. Parham at (410) 786–4669. 

SUPPLEMENTARY INFORMATION: 

Contents 

This notice sets out a summary of the 

use and burden associated with the 

following information collections. More 

detailed information can be found in 

each collection’s supporting statement 

and associated materials (see 

ADDRESSES). 

CMS–10416 Blueprint for Approval of 

State-Based Exchange 

Under the PRA (44 U.S.C. 3501– 

3520), federal agencies must obtain 

approval from the Office of Management 

and Budget (OMB) for each collection of 

information they conduct or sponsor. 

The term ‘‘collection of information’’ is 

defined in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA 

requires federal agencies to publish a 

60-day notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension or reinstatement of an existing 

collection of information, before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, CMS is publishing this 

notice. 

Information Collection 

1. Type of Information Collection 

Request: Extension of a currently 

approved collection; Title of 

Information Collection: Blueprint for 

Approval of State-based Exchange; Use: 

The Patient Protection and Affordable 

Care Act (ACA) and its implementing 

regulations provide states with 

flexibility in the design and operation of 

Exchanges to ensure states are 

implementing Exchanges that best meet 

the needs of their consumers. States can 

choose to establish and operate a Statebased Exchange (SBE) or a State-based 

Exchange on the Federal Platform (SBE– 

FP). To ensure a state can operate a 

successful and compliant SBE or SBE– 

FP, it is critical that states provide CMS 

with a complete and thorough Exchange 


jspears on DSK121TN23PROD with NOTICES1
19690 Federal Register / Vol. 87, No. 65 / Tuesday, April 5, 2022 / Notices 

Blueprint Application, Declaration of 

Intent Letter, and attest to demonstrate 

operational readiness. The information 

collected from states will be used by 

CMS, IRS, SSA and reviewed by other 

Federal agencies to determine if a state 

can implement a complete and fully 

operational Exchange. Form Number: 

CMS–10416 (OMB control number: 

0938–1172); Frequency: Annually; 

Affected Public: State, Local, or Tribal 

governments; Number of Respondents: 

4; Total Annual Responses: 21; Total 

Annual Hours: 126. (For policy 

questions regarding this collection 

contact Shilpa Gogna at 301–492–4257.) 

Dated: March 30, 2022. 

William N. Parham, III, 

Director, Paperwork Reduction Staff, Office 

of Strategic Operations and Regulatory 

Affairs. 

[FR Doc. 2022–07100 Filed 4–4–22; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Therapeutic 

Development and Preclinical Studies. 

Date: April 14, 2022. 

Time: 10:00 a.m. to 2:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Richard D Schneiderman, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

Bethesda, MD 20817, 301–402–3995, 

richard.schneiderman@nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 30, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–07115 Filed 4–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA Panel: 

Tobacco Regulatory Science A. 

Date: May 5, 2022. 

Time: 10:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Sepandarmaz Aschrafi, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4040D, 

Bethesda, MD 20892, (301) 451.4251, 

Armaz.aschrafi@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: March 31, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–07149 Filed 4–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; Stem Cell III. 

Date: April 29, 2022. 

Time: 1:30 p.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Nijaguna Prasad, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, National Institute on Aging, 7201 

Wisconsin Avenue, Gateway Bldg., Suite 

2W200, Bethesda, MD 20892, (301) 496–9667 

prasadnb@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: March 30, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–07110 Filed 4–4–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 


jspears on DSK121TN23PROD with NOTICES1